You just read:

DMD Therapeutics Inc. Receives Funding from DMD Foundations to Develop DMD-813 for Treatment of Duchenne Muscular Dystrophy

News provided by

DMD Therapeutics Inc.

Feb 24, 2017, 08:00 ET